Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion type Assertion NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_head.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion description "[In this study, based on another hypothesis in which estrogen metabolites can directly cause DNA damage and affect tumor initiation, we examined whether the polymorphisms of the estrogen-metabolizing enzymes (EME), which are involved in biogenesis (CYP17, CYP19), bioavailability (CYP1A1, CYP1B1), and degradation (catechol-O-methyltransferase) of the estrogens, have any bearing on the risk for hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_provenance.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion evidence source_evidence_literature NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_provenance.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion SIO_000772 19064581 NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_provenance.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion wasDerivedFrom befree-2016 NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_provenance.
- NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_assertion wasGeneratedBy ECO_0000203 NP707841.RAn5lHlbsSyC6REgxchNl7xm2ZF0ManVflRnyW0V0avLs130_provenance.